Menu
No results found.
“Patience reduces risk more reliably than prediction.”
Weekly Share Price & Valuation Overview
Andlauer Healthcare Group Inc.
Andlauer Healthcare Group Inc., a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics. It provides logistics and distribution services, including client and customer integration, transportation and inventory management, distribution and fulfillment, and warehousing solutions; and packaging services, such as co-packing and re-packing, assembly, and custom work services, as well as design, supply, and secondary Rx packaging services. The company also offers temperature-controlled services; air freight forwarding services; dedicated and last mile delivery services; and ground transportation services, including less-than-truckload, pick-up and delivery, and courier services, as well as carrier options. It serves healthcare manufacturers, wholesalers, distributors, 3PL providers, and others through a platform of technology-enabled supply chain solutions for a range of products, including pharmaceuticals, vaccines, biologics, blood products, narcotics, precursors, active pharmaceutical ingredients, over-the-counter, cosmetics, health and beauty aids, and medical devices, as well as natural, animal, and consumer health. The company was founded in 1991 and is headquartered in Vaughan, Canada. Andlauer Healthcare Group Inc. operates as a subsidiary of Andlauer Management Group Inc.
- High gross margin (≥35%) suggests strong pricing power or cost control.
- Double-digit profit margin (≥10%) supports robust bottom-line economics.
- ROE ≥15% reflects strong returns on shareholder equity.
- ROA ≥7% shows efficient use of assets.
- Quick ratio ≥1.0 indicates obligations can be met without inventory.
- Market Cap Total equity value of the company (share price × shares outstanding).
- CAD 2.09B
- Enterprise Value Operating value: market cap + total debt − cash.
- CAD 2.21B
- Total Revenue (TTM) Estimated Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
- CAD 304.02M
- Gross Profit (TTM) Revenue minus cost of goods sold over the last twelve months. Hidden for financial institutions or if redundant.
- CAD 220.20M
- EBITDA (TTM) Earnings before interest, taxes, depreciation and amortization (TTM). Hidden for financials or if implausible.
- CAD 104.26M
- Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
- CAD 16.57
- EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
- 1.70
- Shares Outstanding
- 18.34M
- Float Shares
- 17.89M
- Implied Shares Outstanding
- 39.15M
- Operating Margin (TTM) Operating income ÷ revenue over the last twelve months (reconciled when possible).
-
12.05%
- EBITDA Margin (TTM) Reconciled EBITDA ÷ revenue over the last twelve months (suppressed if EBITDA implausible/financials).
-
34.29%
- Gross Margin (TTM) Reconciled Strong Gross profit ÷ revenue over the last twelve months (reconciled when possible).
-
72.43%
- Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
-
10.37%
- ROA Strong Return on assets: net income ÷ total assets.
-
8.45%
- ROE Excellent Return on equity: net income ÷ shareholder equity.
-
16.00%
- Revenue Growth Year-over-year revenue growth.
-
-3.00%
- Earnings Growth (YoY) Year-over-year earnings growth.
-
-10.50%
- Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
-
-14.50%
- Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
- 1.25
- Debt to Equity Total debt ÷ shareholder equity; leverage.
- 0.41
- Total Cash Cash and equivalents.
- CAD 58.98M
- Total Debt Short + long-term interest-bearing debt.
- CAD 178.14M
- Net Debt Total debt − cash (negative = net cash).
- CAD 119.16M
- Debt / EBITDA Leverage relative to operating earnings; lower is safer.
- 1.71
- Operating Cash Flow (TTM) Cash generated by core operations (pre-capex).
- CAD 122.25M
- Free Cash Flow (TTM) Cash after capex; funds buybacks, dividends, and debt paydown.
- CAD 99.21M
- OCF Margin (TTM) Operating cash flow ÷ revenue (TTM).
-
40.21%
- FCF Margin (TTM) Free cash flow ÷ revenue (TTM).
-
32.63%
- Cash Conversion (OpCF/EBITDA)
- 1.17
- Total Revenue (TTM) estimated from Revenue per Share × Shares due to feed inconsistency.
- Dividend Yield suppressed due to an anomalous value from the feed (>30%).
- Margins shown on a TTM basis. “Reconciled” = numerator ÷ TTM revenue for internal consistency.
- Cash Flow section is displayed only when figures are self-consistent (and hidden for financials).
Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.